Gene · 406887
Papers2,462
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,462
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-coding RNAs in cancer immunotherapy: Predictive biomarkers and targets. | Clin Transl Med | 2023 | 37735815 | PubTator, text mining | PubMed |
| Extracellular vesicle-based liquid biopsies in cancer: Future biomarkers for oral cancer. | Transl Oncol | 2023 | 37713973 | PubTator, text mining | PubMed |
| Biological roles of RNA m7G modification and its implications in cancer. | Biol Direct | 2023 | 37710294 | PubTator, text mining | PubMed |
| Function and mechanism of MCM8 in the development and progression of colorectal cancer. | J Transl Med | 2023 | 37710286 | PubTator, text mining | PubMed |
| Research progress on the role of extracellular vesicles in neurodegenerative diseases. | Transl Neurodegener | 2023 | 37697342 | PubTator, text mining | PubMed |
| Exploring the Feasibility of Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Osteoarthritis: Challenges and Opportunities. | Int J Mol Sci | 2023 | 37685951 | PubTator, text mining | PubMed |
| Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma. | World J Gastroenterol | 2023 | 37664153 | PubTator, text mining | PubMed |
| Clinically informative microRNAs for SARS-CoV-2 infection. | Epigenomics | 2023 | 37661862 | PubTator, text mining | PubMed |
| Genetics in ophthalmology: molecular blueprints of retinoblastoma. | Hum Genomics | 2023 | 37658463 | PubTator, text mining | PubMed |
| Four differentially expressed exosomal miRNAs as prognostic biomarkers and therapy targets in endometrial cancer: Bioinformatic analysis. | Medicine (Baltimore) | 2023 | 37653757 | PubTator, text mining | PubMed |
| Sexually dimorphic extracellular vesicle responses after chronic spinal cord injury are associated with neuroinflammation and neurodegeneration in the aged brain. | J Neuroinflammation | 2023 | 37653491 | PubTator, text mining | PubMed |
| Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles. | Front Oncol | 2023 | 37637043 | PubTator, text mining | PubMed |
| Tumor Markers and Their Diagnostic Significance in Ovarian Cancer. | Life (Basel) | 2023 | 37629546 | PubTator, text mining | PubMed |
| Advancing Breast Cancer Heterogeneity Analysis: Insights from Genomics, Transcriptomics and Proteomics at Bulk and Single-Cell Levels. | Cancers (Basel) | 2023 | 37627192 | PubTator, text mining | PubMed |
| ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See! | Biomedicines | 2023 | 37626796 | PubTator, text mining | PubMed |
| Effects of Controlled Ozone Exposure on Circulating microRNAs and Vascular and Coagulation Biomarkers: A Mediation Analysis. | Noncoding RNA | 2023 | 37624035 | PubTator, text mining | PubMed |
| Crosstalk between Long Non-Coding RNA and Spliceosomal microRNA as a Novel Biomarker for Cancer. | Noncoding RNA | 2023 | 37624034 | PubTator, text mining | PubMed |
| RNA modification: mechanisms and therapeutic targets. | Mol Biomed | 2023 | 37612540 | PubTator, text mining | PubMed |
| P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC. | J Exp Clin Cancer Res | 2023 | 37599359 | PubTator, text mining | PubMed |
| LncRNA SNHG4 promotes prostate cancer cell survival and resistance to enzalutamide through a let-7a/RREB1 positive feedback loop and a ceRNA network. | J Exp Clin Cancer Res | 2023 | 37596700 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406887/papers?page=6